Vera Therapeutics, Inc. (VERA) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $35.53 -1%
EPS Growth %: -27.8%
Financial Fact:
NET INTEREST INCOME: 17.73K
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -27.8%
Financial Fact:
NET INTEREST INCOME: 17.73K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($0.62), $0.06 worse than the analyst estimate of ($0.56).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
- Akari Therapeutics to present ADC platform at five September conferences
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
